Daily News Pulse for February 02, 2023
February 2, 2023
Summary: A new study has found that the BNT162b2 COVID-19 vaccine provides strong and sustained protection against the Delta variant, but lower protection against the Omicron variant among adolescents. A preprint suggests that molnupiravir, a widely used COVID-19 drug, may be driving the appearance of new SARS-CoV-2 variants. Kansas and South Dakota are the only states without long COVID clinics, leaving people with lingering symptoms without treatment.
